Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. SPY
6. NVDA
7. MSFT
8. LEVI
9. SKYD
10. APLD

Go back to Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

June 23, 2026 8:05 AM EDT

Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for all stakeholders

Lilly and Astellas to serve as stalking horse bidders in a court-supervised auction process

Sangamo has secured commitment for debtor-in-possession (DIP) financing to support ongoing operations

RICHMOND, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company, today announced that it has entered into two separate asset sale agreements, one with Eli... More